Clinical Research Ventures

Clinical Research Ventures is a global life-science investor that focuses exclusively on companies seeking funding for their clinical trials in pharmaceuticals, diagnostics, and other medical technologies. The firm does not invest in purely pre-clinical rounds. By partnering with top-tier clinical research organizations, Clinical Research Ventures aims to achieve rapid startup, enrollment, and successful trial completion in a time and capital-efficient manner for its portfolio companies. The firm has offices in Boston and Europe, investing worldwide.

The firm's investment strategy centers on supporting companies entering Phase I and II clinical trials, with a commitment to invest up to US$50 million annually in clinical trial and related costs. Clinical Research Ventures invests alongside existing or new investors, typically as a follower, underwriting up to the majority of the funding. The firm has a history of investing in companies such as Astrocyte Pharmaceuticals, Inc., which is developing innovative neuroprotective therapies for traumatic brain injuries, stroke, and concussions.

Clinical Research Ventures emphasizes active management of its portfolio companies, leveraging its regulatory and clinical development expertise to accelerate clinical development and regulatory approval. The firm collaborates with a network of investors and funds, each with their individual specialty, to create global leaders in their respective markets. This approach enables Clinical Research Ventures to support companies in achieving value milestones faster than with conventional venture capital, thereby advancing medical breakthroughs and improving patient outcomes.